The Future of Personalized Medicine for Patients to Improve Healthcare Access with Jesse Vidrine
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
Compounding pharmacies have rapidly moved from a niche corner of healthcare into the national spotlight, driven largely by the demand for GLP-1 medications and growing interest in personalized medicine. In this episode of Compounding Interest: The Business of Personalized Medicine, host Amy Summers sits down with Jesse Vidrine, President of Boudreaux's New Drugstore and Vidrine Pharmaceutical Group, to discuss how compounding is evolving, the regulatory landscape, the future of hormones, peptides, telehealth, AI, and what it will take to make personalized medicine more accessible for patients.
Jesse Vidrine is the President of Vidrine Pharmaceutical Group, the parent company of Boudreaux's New Drugstore, a nationally licensed 503A compounding pharmacy based in South Louisiana. With decades of experience in hormone replacement therapy and personalized medicine, Jesse is focused on expanding patient access to customized therapies while advancing quality, compliance, automation, and innovation within the compounding pharmacy industry.
Key Takeaways
- Why compounding pharmacies have become significantly more visible over the past few years.
- What the GLP-1 movement revealed about drug pricing, access, and the broader healthcare system.
- How hormones, peptides, telehealth, and testing are shaping the future of personalized medicine.
- The regulatory challenges facing compounding pharmacies and why compliance is becoming more important than ever.
- How AI, automation, and technology can improve patient care while maintaining clinical quality.
Timestamps
[00:00] – Episode Preview
[01:35] – Meet Jesse Vidrine
[02:35] – How Compounding Went Mainstream
[05:48] – What GLP-1s Revealed About Healthcare
[13:09] – The Future of Personalized Medicine
[17:46] – Hormones, Individualized Care & Clinical Need
[20:01] – Customization vs. Commercial Medicine
[27:16] – Peptides, Regulation & Industry Responsibility
[33:30] – Telehealth, AI & Pharmacy Innovation
[39:27] – Testing, Long-Term Vision & Closing Thoughts
Follow Jesse Vidrine:
- LinkedIn: https://www.linkedin.com/in/jesse-vidrine-377a4b6b/
- Website (Company): https://vpgrx.com/
Follow the Host:
- Amy Summers: https://www.linkedin.com/in/amy-summers-pharmd-bcscp-fapc-20b04a93/
- Restore Health Consulting: https://www.restorehealthconsulting.com/
Follow The Podcast:
- YouTube: https://www.youtube.com/@RestoreHealthConsulting
- Spotify: https://open.spotify.com/show/033F4FRUbjSrN1oNbfozhD?si=caf30ccfd2ba49b6
- Apple Podcasts: https://podcasts.apple.com/in/podcast/compounding-interest/id6784679391